Powder Delivery TRIZ Cases

Acid-immersed silica microspheres lower density to prevent rapid sedimentation while maintaining stable yttrium load for selective internal radiation therapy.

Self-assembled cyclometalated iron nanoparticles overcome low conversion efficiency and structural instability in biological environments.

Topical free radical scavengers neutralize oxidative stress on skin and scalp surfaces, reducing chemotherapy-induced dryness and hair loss.

A differential T cell activation potential metric evaluates mRNA vaccine quality to guide formulation development.

Periodic picotamide administration manages migraine with aura while reducing side effects and drug accumulation via defined treatment and interruption cycles.

A multi-herb composition reduces brain edema and infarction volume through synergistic pharmacological actions.

Co-suspension compositions prevent particle aggregation in non-CFC propellants, ensuring consistent aerosol performance and dose uniformity.

Sequential extraction removes CBD crystals from solution, preventing precipitation during vaporization while maintaining high purity.

HP-β-CD and methionine inhibit aggregate formation in lyophilized peptide mixtures, enabling single-vial reconstitution.

Substituting glycerol with isosorbide eliminates the greasy and tacky feel while maintaining effective skin hydration.

Pre-coating DNA nanostructures with endolysosomal escape peptides overcomes protein corona interference to improve vesicle release efficiency.

A nanocomplex binds a modified protein to a lipid-like nanoparticle via non-covalent interaction.

Segmented nanoparticles combine Factor VIIa inhibition and nitric oxide donation to treat pulmonary hypertension while reducing side effects.

Apigenin and berberine compositions reduce infectious titers despite limited efficacy of existing antivirals.

Prodrug structure metabolizes to release capsaicin, extending pain relief duration and reducing opioid side effects.

Non-covalent binding of C13-C27 fatty acids to silica particles modulates microbiota-host interactions, replacing complex probiotics with a verifiable mediator.

Dry powder formulations deliver dihydroergotamine via passive inhalation, resolving injection complexity and poor bioavailability.

Ropivacaine suspension injection extends analgesic duration to 72 hours by maintaining median particle sizes between 1 and 40 micrometers.

Inhalable dry powder insulin mimics natural early-phase secretion, reducing severe hypoglycemic events by up to 30 percent compared to subcutaneous injections.

Amphiphilic plant protein shells encapsulate hydrophobic compounds, resolving poor aqueous solubility and low bioavailability of active ingredients.

Segmented bead sizes address conflicting vessel penetration and embolization requirements in transarterial chemoembolization.

Salt medium fine-pulverization reduces particle size while removing contaminants, preventing re-aggregation through carboxyvinyl polymer coverage.

Controlling d(v,0.5) and d(v,0.9) parameters prevents cohesion-driven agglomerates, ensuring uniform active ingredient distribution in low-dosage inhalers.

A composite nutraceutical combines palmitoylethanolamide, curcumin, and piperine to modulate inflammatory pathways.

Micronized polylactic acid powders resolve the trade-off between cosmetic performance and environmental friendliness by replacing synthetic polymers.

Pre-sintered tricalcium phosphate particles provide enhanced compressive strength and rapid setting for bone repair cements without complex manufacturing.

Optimized carrier particle size ratios prevent agglomeration of fine active ingredients, resolving content uniformity challenges in dry powder inhalers.

Adjusting the noncrystallizing plasticizer to glycerol weight ratio in alginate films balances break strength with rapid intestinal disintegration.

Direct amphiphilic dye absorption on hydrophobic particles eliminates complex surface modification steps while maintaining dual-modal imaging capabilities.

Targeting peptides on the nanoparticle surface direct siRNA to specific tissues, reducing off-target effects and cytotoxicity.

Standardized turmeric, boswellia, and ginger extracts inhibit inflammatory mediators while reducing blood clot risks associated with NSAID therapies.

A horizontal lyophilization syringe assembly uses a vented stopper to seal contents after drying.

A Chinese medicine composition delays Aβ-induced paralysis in C. elegans models.

Segmenting enzyme preparations into coated and uncoated beads resolves stability versus release speed trade-offs.

A recombinant nucleic acid construct uses specific 5' and 3' UTR sequences to drive high effector molecule expression in target cells.

A hybrid coating of polyvinyl acetate and enteric polymer ensures sustained release from an opioid ion exchange resin complex.

Oscillating capsule impacts and Venturi airflow velocity resolve inconsistent medicament release in dry powder inhalers.

A solid co-amorphous dispersion of valsartan, nicotinamide, and an amphiphilic solvent enhances water solubility.

Oxidized coenzyme Q composition stimulates salivary secretion to relieve dry mouth symptoms.

Combining Elafibranor with Obeticholic acid creates a synergistic pharmaceutical composition.

Water-soluble curcumin resolves low bioavailability by increasing mitochondrial mass and PGC-1α expression, reducing oxidative stress during intense exercise.

Spherical nucleic acids with sheddable PEG layers restore cellular uptake after systemic circulation.

Polymeric particle backpacks resolve binding efficacy versus versatility trade-offs by attaching multiple distinct binding reagents to a single carrier.

Amorphous solid dispersion of linagliptin with carriers stabilizes the drug against hygroscopicity and polymorphic instability.

Oolitic aragonite particles replace plastic microbeads to deliver scrubbing effectiveness while eliminating environmental pollution and toxicity.

A herbal powder formulation regulates intestinal flora and protects gastric mucosa using natural extracts.

Replacing PEG with poly(sialic acid) coatings reduces renal clearance and immune recognition while maintaining therapeutic stability.

Offset lateral vents create turbulent airflow patterns that deagglomerate high-dose cohesive powders, reducing retention and improving respiratory delivery.